Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 61 | — | ASCENDIS PHARMA A/S | — | 3,830.0 | $876K | 0.24% | +730.0 | +23.6% | $228.73 | — |
| 62 | SRPT | SAREPTA THERAPEUTICS INC | Healthcare | 39,213.0 | $853K | 0.23% | +7K | +23.5% | $21.76 | -14.2% |
| 63 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 11,234.0 | $834K | 0.23% | +2K | +23.6% | $74.26 | -10.9% |
| 64 | ARDX | ARDELYX INC | Healthcare | 135,954.0 | $814K | 0.23% | +26K | +23.5% | $5.99 | +4.0% |
| 65 | BNTX | BIONTECH SE | Healthcare | 8,904.0 | $791K | 0.22% | +2K | +23.6% | $88.88 | +0.8% |
| 66 | AUPH | AURINIA PHARMACEUTICALS INC | Healthcare | 53,267.0 | $789K | 0.22% | +10K | +23.5% | $14.82 | +3.1% |
| 67 | — | BEONE MEDICINES LTD | — | 2,646.0 | $786K | 0.22% | +505.0 | +23.6% | $296.97 | — |
| 68 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 10,445.0 | $784K | 0.22% | +2K | +23.6% | $75.09 | +3.3% |
| 69 | MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | 1,476.0 | $773K | 0.21% | +282.0 | +23.6% | $523.47 | +3.1% |
| 70 | PTCT | PTC THERAPEUTICS INC | Healthcare | 11,160.0 | $760K | 0.21% | +2K | +23.6% | $68.13 | +6.7% |
| 71 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 12,045.0 | $755K | 0.21% | +2K | +23.6% | $62.70 | +22.3% |
| 72 | TBPH | THERAVANCE BIOPHARMA INC | Healthcare | 46,464.0 | $754K | 0.21% | +9K | +23.5% | $16.23 | +1.7% |
| 73 | PNNT | PENNANTPARK INVT CORP | Financial Services | 165,540.0 | $743K | 0.20% | +42K | +34.4% | $4.49 | -5.8% |
| 74 | FSK | FS KKR CAP CORP | Financial Services | 72,227.0 | $735K | 0.20% | +9K | +14.8% | $10.18 | +6.1% |
| 75 | TARS | TARSUS PHARMACEUTICALS INC | Healthcare | 10,378.0 | $728K | 0.20% | +2K | +23.6% | $70.15 | -7.1% |
| 76 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 5,524.0 | $728K | 0.20% | +1K | +23.5% | $131.74 | +20.7% |
| 77 | TVTX | TRAVERE THERAPEUTICS INC | Healthcare | 24,239.0 | $720K | 0.20% | +5K | +23.5% | $29.71 | +48.4% |
| 78 | CRSP | CRISPR THERAPEUTICS AG | Healthcare | 14,894.0 | $709K | 0.20% | +3K | +23.5% | $47.57 | +6.1% |
| 79 | INSM | INSMED INC | Healthcare | 4,283.0 | $700K | 0.19% | +815.0 | +23.5% | $163.52 | -29.3% |
| 80 | NMFC | NEW MTN FIN CORP | Financial Services | 89,471.0 | $694K | 0.19% | +4K | +4.2% | $7.76 | +3.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
30.6%
Financial Services
23.4%
Industrials
11.2%
Technology
10.7%
Consumer Cyclical
7.6%
Energy
3.4%
Basic Materials
3.4%
Communication Services
3.1%
Consumer Defensive
2.9%
Real Estate
2.2%